Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lori, Sahakian"'
Autor:
Manpreet Singh, Maureen McMahon, Brian Skaggs, Jennifer Grossman, Lori Sahakian, Caroline Siegel, Lisa Zhu, Jordan Jacquez, Sam Good
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/db2b0b364fcb4811b2c1f7c3454a5d71
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
Autor:
Manpreet Singh, Maureen McMahon, Jennifer Grossman, Lori Sahakian, Bevra Hahn, Lisa Zhu, Sonia Lele
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Objectives Traditional cardiovascular risk calculators such as the Framingham Risk Score (FRS) have been shown to underestimate risk in patients with SLE. The QRISK3 calculator is unique in including SLE and corticosteroid use as risk factors. This s
Externí odkaz:
https://doaj.org/article/68547a092f3f475ea79816a4907e43ca
Autor:
Brian J. Skaggs, Jennifer Grossman, Lori Sahakian, Lucas Perry, John FitzGerald, Christina Charles‐Schoeman, Alan Gorn, Mihaela Taylor, John Moriarty, Nagesh Ragavendra, Michael Weisman, Daniel J. Wallace, Bevra H. Hahn, Maureen McMahon
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 4, Pp 209-220 (2021)
Objective The increase in cardiovascular events (CVEs) in systemic lupus erythematosus (SLE) is not fully explained by traditional risk factors. We previously identified four biomarkers (proinflammatory high‐density lipoprotein, leptin, soluble TNF
Externí odkaz:
https://doaj.org/article/02966150902547ddb3354a6c17ef0378
Autor:
Michael H. Weisman, Daniel J. Wallace, Lori Sahakian, Bevra H. Hahn, John FitzGerald, John M. Moriarty, Lucas Perry, Christina Charles-Schoeman, Mihaela Taylor, Maureen McMahon, Nagesh Ragavendra, Jennifer M. Grossman, Brian J. Skaggs, Alan Gorn
Publikováno v:
ACR Open Rheumatology
ACR Open Rheumatology, Vol 3, Iss 4, Pp 209-220 (2021)
ACR open rheumatology, vol 3, iss 4
ACR Open Rheumatology, Vol 3, Iss 4, Pp 209-220 (2021)
ACR open rheumatology, vol 3, iss 4
ObjectiveThe increase in cardiovascular events (CVEs) in systemic lupus erythematosus (SLE) is not fully explained by traditional risk factors. We previously identified four biomarkers (proinflammatory high-density lipoprotein, leptin, soluble TNF-li
Autor:
Carole S. L. Spake, Ellis M. Berns, Lori Sahakian, Adrian Turcu, Ahsia Clayton, Jillian Glasser, Caitlin Barrett, Douglas Barber, Valentin Antoci, Christopher T. Born, Dioscaris R. Garcia
Publikováno v:
Journal of orthopaedic research : official publication of the Orthopaedic Research SocietyREFERENCES. 40(10)
Prevention and treatment of orthopedic device-related infection (ODRI) is complicated by the formation of bacterial biofilms. Biofilm formation involves dynamic production of macromolecules that contribute to the structure of the biofilm over time. L
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
Autor:
Lisa Zhu, Manpreet Singh, Sonia Lele, Lori Sahakian, Jennifer Grossman, Bevra Hahn, Maureen McMahon
Publikováno v:
Lupus sciencemedicine. 9(1)
ObjectivesTraditional cardiovascular risk calculators such as the Framingham Risk Score (FRS) have been shown to underestimate risk in patients with SLE. The QRISK3 calculator is unique in including SLE and corticosteroid use as risk factors. This st
Autor:
Maureen McMahon, Bevra H. Hahn, Jennifer M. Grossman, Brian J. Skaggs, Lori Sahakian, Weng Kee Wong, Weiling Chen
Publikováno v:
Lupus Science & Medicine
ObjectivePatients with SLE have an increased risk of atherosclerosis (ATH) that is not adequately explained by traditional risk factors. We previously described the Predictors of Risk for Elevated Flares, Damage Progression, and Increased Cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff50178b4631f013a36ea051f86ae85b
https://escholarship.org/uc/item/9wz962b4
https://escholarship.org/uc/item/9wz962b4
Autor:
Ratushtar Kapadia, Oria Lu, Harrison Lam, Jennifer Grossman, Caroline Siegel, Ruta Tesfamicael, Maureen McMahon, Lori Sahakian
Publikováno v:
Abstracts.
Background Systemic Lupus Erythematosus (SLE) is a heterogeneous disease that can cause multisystem inflammation and damage. There are currently no widely agreed upon targets for determining adequate disease control. Lupus Low Disease Activity State
Autor:
Mary Katherine Miller, Lori Sahakian, Emily Morell, Elizabeth D. Blume, Jeffrey R. Reichman, Angela M. Feraco, Sarah Goldberg, Lynn A. Sleeper
Publikováno v:
Journal of Pain and Symptom Management. 59:564
Autor:
Lori Sahakian, Sarah Chen, Maureen McMahon, Jennifer M. Grossman, Caroline H. Siegel, Michael B. Gorin
Publikováno v:
Tissue Damage.
Background There is ample evidence demonstrating that hydroxychloroquine (HCQ) prevents lupus flares, increases long-term survival, and protects against irreversible organ damage in SLE (Pons-Estel Arth Care Res 2010). However, in recent years, ophth